Literature DB >> 33352845

Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?

Thorsten H Ecke1, Thomas Otto2, Florence Le Calvez-Kelm3.   

Abstract

In the last few years, we published two special issues devoted to highlighting important scientific results in the field of bladder cancer research and clinical implications [...].

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33352845      PMCID： PMC7766346          DOI： 10.3390/ijms21249657

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN： 1422-0067            Impact factor:   5.923


  24 in total

Review 1.  The 2004 WHO classification of bladder tumors: a summary and commentary.

Authors:  Rodolfo Montironi; Antonio Lopez-Beltran
Journal:  Int J Surg Pathol       Date:  2005-04       Impact factor: 1.271

Review 2.  The Paris System for Reporting Urinary Cytology: the quest to develop a standardized terminology.

Authors:  Güliz A Barkan; Eva M Wojcik; Ritu Nayar; Spasenija Savic-Prince; Marcus L Quek; Daniel F I Kurtycz; Dorothy L Rosenthal
Journal:  J Am Soc Cytopathol       Date:  2016-04-19

Review 3.  The economics of bladder cancer: costs and considerations of caring for this disease.

Authors:  Robert S Svatek; Brent K Hollenbeck; Sten Holmäng; Richard Lee; Simon P Kim; Arnulf Stenzl; Yair Lotan
Journal:  Eur Urol       Date:  2014-01-21       Impact factor: 20.096

4.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

5.  Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.

Authors:  Woonyoung Choi; Sima Porten; Seungchan Kim; Daniel Willis; Elizabeth R Plimack; Jean Hoffman-Censits; Beat Roth; Tiewei Cheng; Mai Tran; I-Ling Lee; Jonathan Melquist; Jolanta Bondaruk; Tadeusz Majewski; Shizhen Zhang; Shanna Pretzsch; Keith Baggerly; Arlene Siefker-Radtke; Bogdan Czerniak; Colin P N Dinney; David J McConkey
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

6.  Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.

Authors:  Dan Theodorescu; Stefan Wittke; Mark M Ross; Michael Walden; Mark Conaway; Ingo Just; Harald Mischak; Henry F Frierson
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

Review 7.  Genetic alterations in urothelial bladder carcinoma: an updated review.

Authors:  Paulette Mhawech-Fauceglia; Richard T Cheney; Juerg Schwaller
Journal:  Cancer       Date:  2006-03-15       Impact factor: 6.860

8.  Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer.

Authors:  Patrice Hodonou Avogbe; Arnaud Manel; Emmanuel Vian; Geoffroy Durand; Nathalie Forey; Catherine Voegele; Maria Zvereva; Md Ismail Hosen; Sonia Meziani; Berengere De Tilly; Gilles Polo; Olesia Lole; Pauline Francois; Tiffany Myriam Delhomme; Christine Carreira; Sara Monteiro-Reis; Rui Henrique; Behnoush Abedi-Ardekani; Graham Byrnes; Matthieu Foll; Elisabete Weiderpass; James McKay; Carmen Jeronimo; Ghislaine Scelo; Florence Le Calvez-Kelm
Journal:  EBioMedicine       Date:  2019-05-20       Impact factor: 8.143

9.  Comprehensive molecular characterization of urothelial bladder carcinoma.

Authors: 
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

Review 10.  Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer.

Authors:  Maria Zvereva; Eduard Pisarev; Ismail Hosen; Olga Kisil; Simon Matskeplishvili; Elena Kubareva; David Kamalov; Alexander Tivtikyan; Arnaud Manel; Emmanuel Vian; Armais Kamalov; Thorsten Ecke; Florence Le Calvez-Kelm
Journal:  Int J Mol Sci       Date:  2020-08-21       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.